is semaglutide a controlled drug Poison control data shows significant increase in weight-loss overdoses Semaglutide in Winter Garden |

The 20% reduction in cardiovascular events seen in the SELECT trial may not be entirely explained by weight loss

Progress becomes harder to sustain

Safety Information and Proper Use Aseptic Technique: The Critical Foundation for Multi-Dose Safety The safety of bacteriostatic water in multi-dose vials depends entirely on aseptic techniquethe use of sterile equipment and procedures to prevent contamination

14.3 MOUNJARO Use in Combination with Metformin, Sulfonylureas, and/or SGLT2 Inhibitors in Adult Patients with Type 2 Diabetes Mellitus Add-on to metformin SURPASS-2 (NCT03987919) was a 40-week open-label trial (double-blind with respect to MOUNJARO dose assignment) that randomized 1879 adult patients with type 2 diabetes mellitus with inadequate glycemic control on stable doses of metformin alone to the addition of subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or MOUNJARO 15 mg once weekly or subcutaneous semaglutide 1 mg once weekly

This can range from relatively straightforward lifestyle and diet changes, to new medications, to even surgery in some rarer cases

It is important to note that this mechanism is a plausible hypothesis based on what is understood about GLP-1-based therapies more broadly